| [1] |
Calabrò F, Sternberg CN. Neoadjuvant and adjuvant chemotherapy in muscle-invasive bladder cancer[J]. Eur Urol, 2009, 55(2): 34 8-58.
|
| [2] |
Yang Y, Lei Y, Qin Y, et al. Bladder-sparing surgery combined internal lliac artery chemotherapy for invasive bladder cancer(report of 46 cases)[J]. Lin Chuang Mi Niao Wai Ke Za Zhi, 2009, 24(12): 908-10. [杨勇, 雷永红, 秦扬, 等. 保留膀胱联 合髂内动脉化疗治疗浸润性膀胱癌46例报告[J]. 临床泌尿外科 杂志, 2009, 24(12): 908-10.]
|
| [3] |
Niu YN, Yan Y, Zhang JH, et al. Safety and efficacy of intraarterial infusion neoadjuvant chemotherapy for local advanced bladder cancer[J]. Zhonghua Mi Niao Wai Ke Za Zhi, 2009, 30 (10): 681-3. [牛亦农, 闫勇, 张军晖, 等. 局部晚期膀胱癌术前 动脉灌注新辅助化疗的安全性与疗效分析[J]. 中华泌尿外科杂 志, 2009, 30(10): 681-3.]
|
| [4] |
Yao QS, Wang XK, Yang Y, et al. Intra-artery infusion chemotherapy plus sequential intravesical instillation for the prevention of bladdercancer recurrence after TUR-BT[J]. Xian Dai Mi Niao Sheng Zhi Zhong Liu Za Zhi, 2009, 1(5): 276-8. [ 姚启盛, 王小康, 杨勇, 等. 髂内动脉灌注化疗联合双联灌注预防膀胱肿 瘤电切术后复发[J]. 现代泌尿生殖肿瘤杂志, 2009, 1(5): 276-8.]
|
| [5] |
Azuma H, Inamoto T, Takahara K, et al. Neoadjuvant and adjuvant chemotherapy for locally advanced bladder carcinoma: development of novel bladder preservation approach, Osaka Medical College regimen[J]. Int J Urol, 2012, 19(1): 26-38.
|
| [6] |
Chen J, Yao Z, Qiu S, et al. Comparing intra-arterial chemotherapy combined with intravescial chemotherapy versus intravesical chemotherapy alone:A randomised prospective pilot study for T1G3 bladder transitional cell carcinoma after bladder-preserving surgery[J]. Cardiovasc Intervent Radiol, 2013, 36(6): 1521-6.
|
| [7] |
Terashima Y. CDDP concentration of bladder tumors--comparison between intraarterial infusion and intravenous infusion[J]. Nihon Gan Chiryo Gakkai Shi, 1988, 23(4): 859-66.
|
| [8] |
Uyama T, Higa I, Shiotsu T, Doxorubicin intra-arterial chemotherapy combined with low-dose irradiation inbladder cancer[J]. Gan To Kagaku Ryoho, 1987, 14(7): 2293-9.
|
| [9] |
Miyanaga N, Akaza H, Hinotsu S, et al. Background variables for the patients with invasive bladder cancer suitable for bladderpreserving therapy[J]. Jpn J Clin Oncol, 2007, 37(11): 852-7.
|
| [10] |
Nemoto Kaoru, Tsuboi Narumi, Miura Takafumi, et al. Intraarterial combination chemotherapy with maximum transurethral resection of bladder tumor for T1 grade 3 and T2-3N0M0 bladder cancers[J]. J Cancer Sci Ther, 2011, 3(10): 235-8.
|
| [11] |
Jiang L, Zhang Z, Dong P, et al. Efficacy of radical cystectomy plus adjuvant intra-arterial chemotherapy with gemcitabine and cisplatin on locally advanced bladder cancer[J]. Chin Med J(Engl), 2014, 127 (7): 1249-54.
|
| [12] |
Ploussard G, Daneshmand S, Efstathiou JA, et al. Critical analysis of bladder sparing with trimodal therapy in muscle-invasive bladder cancer: a systematic review[J]. Eur Urol, 2014, 66(1): 12 0-37.
|
| [13] |
Hashine K, Kusuhara Y, Miura N, et al. Bladder preservation therapy conducted by intra-arterial chemotherapy and radiotherapy for muscle invasive bladder cancer[J]. Jpn J Clin Oncol, 2009, 39 (6): 381-6.
|
| [14] |
Azuma H, Kotake Y, Yamamoto K, et al. Effect of combined therapy using balloon-occluded arterial infusion of cisplatin andhemodialysis with concurrent radiation for locally invasive bladder cancer[J]. Am J Clin Oncol, 2008, 31(1): 11-21.
|
| [15] |
Azuma H, Yamamoto K, Inamoto T, et al. Total cystectomy versus bladder preservation therapy for locally invasive bladder cancer: effect of combined therapy using balloon-occluded arterial infusion of anticancer agent and hemodialysis with concurrent radiation[J]. Am J Clin Oncol, 2009, 32(6): 592-606.
|
| [16] |
Azuma H, Inamoto T, Ibuki N, et al. Novel bladder preservation therapy for locally invasive bladder cancer: combined therapy using balloon-occluded arterial infusion of anticancer agent and hemodialysis with concurrent radiation[J]. Int J Oncol, 2010, 37 (4): 773-85.
|
| [17] |
Gospodarowicz M. Radiotherapy and organ preservation in bladder cancer: are we ignoring the evidence?[J]. J Clin Oncol, 2002, 20 (14): 3048-50.
|
下载:
